Search Results

Gryphon Investors (“Gryphon”), a leading middle-market private equity firm, today announced that it has acquired Vetnique Labs (“Vetnique” or the “Company”).

Biotech was starting to show signs of recovery after years of investor pullback—until new tariffs and economic uncertainty sent fresh shockwaves through an already fragile market.

- Gryphon Investors (“Gryphon”), a leading middle-market private equity firm, announced today that it has signed a definitive agreement to sell its portfolio company CORA Health Holdings Corp. (“CORA,” “CORA Physical Therapy,” or “the Company”) to an affiliate of H.I.G. Capital. Gryphon originally invested in the Company in July 2016 .